We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) to Buy Back Shares of $1B to Add Shareholder Value
Read MoreHide Full Article
Humana Inc. (HUM - Free Report) has entered into an agreement with Mizuho Markets Americas LLC and Wells Fargo Bank, National Association, to buy back shares worth $1 billion as part of its $3-billion share repurchase program. This $3-billion plan was announced by HUM's board of directors in February 2021 with the expiration date of Feb 18, 2024.
The leading health insurance player has 128.5 million shares remaining under its share buyback plan.
HUM expects its final settlement under the accelerated agreements to take place in the first quarter of 2022. Per the recent 8-K filing, Humana will be making payments in an aggregate amount of $1 billion.
These initiatives reflect the health insurer’s efforts to enhance shareholder’s value.
A few days back, HUM’s shares tumbled after it slashed its Medicare membership growth forecast by around 50% in a recent filing. However, the same improved to some extent following the share buyback announcement. This should instill investor’s confidence in the stock.
This currently Zacks Rank #4 (Sell) player could take these initiatives owing to its impressive solvency level.
As of Sep 30, 2021, Humana had cash, cash equivalents and investment securities of $18.02 billion, higher than its long-term debt of $11.5 billion. Based on a strong financial position, Humana has been efficiently deploying excess capital for the past several years.
Share buybacks and dividend hikes are a prudent way to maximize shareholders’ wealth and generate more value.
This health insurer has also been hiking its dividend since 2011. In December, Humana inked two separate deals with two third-party financial institutions to effect an aggregate $1.75-billion ASR program under its authorization.
Shares of Humana have lost 2.4% in a year’s time against the industry’s growth of 30.2%.
Image Source: Zacks Investment Research
Other companies in the same space being serious about capital deployment through share buybacks include Cigna Corp. (CI - Free Report) , Select Medical Holdings Corporation (SEM - Free Report) and Anthem, Inc. .
Cigna has a strong shareholder value-boosting program in place. CI announced a $2-billion accelerated share repurchase in the third quarter. It also declares special dividends from time to time. Management remains optimistic about paying an attractive dividend and generating a cumulative operating cash flow of $50 billion through 2025.
In the third quarter of 2021, Anthem repurchased shares worth $480 million. ANTM expects to buy back shares worth $1.6 billion for 2021 and around 60% of the target has been achieved so far. Anthem has always been aggressively engaged in share buybacks, utilizing its excess capital to add shareholder value.
After halting share buybacks for a short time, Select Medical resumed the same in the third quarter of 2021. SEM bought back shares worth $47.5 million in the period. Also, the board of directors authorized an increase in its share repurchase program on Nov 2, 2021, which will run until the end of 2023. It lifted the buyback program from $500 million to $1 billion.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Humana (HUM) to Buy Back Shares of $1B to Add Shareholder Value
Humana Inc. (HUM - Free Report) has entered into an agreement with Mizuho Markets Americas LLC and Wells Fargo Bank, National Association, to buy back shares worth $1 billion as part of its $3-billion share repurchase program. This $3-billion plan was announced by HUM's board of directors in February 2021 with the expiration date of Feb 18, 2024.
The leading health insurance player has 128.5 million shares remaining under its share buyback plan.
HUM expects its final settlement under the accelerated agreements to take place in the first quarter of 2022. Per the recent 8-K filing, Humana will be making payments in an aggregate amount of $1 billion.
These initiatives reflect the health insurer’s efforts to enhance shareholder’s value.
A few days back, HUM’s shares tumbled after it slashed its Medicare membership growth forecast by around 50% in a recent filing. However, the same improved to some extent following the share buyback announcement. This should instill investor’s confidence in the stock.
This currently Zacks Rank #4 (Sell) player could take these initiatives owing to its impressive solvency level.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
As of Sep 30, 2021, Humana had cash, cash equivalents and investment securities of $18.02 billion, higher than its long-term debt of $11.5 billion. Based on a strong financial position, Humana has been efficiently deploying excess capital for the past several years.
Share buybacks and dividend hikes are a prudent way to maximize shareholders’ wealth and generate more value.
This health insurer has also been hiking its dividend since 2011. In December, Humana inked two separate deals with two third-party financial institutions to effect an aggregate $1.75-billion ASR program under its authorization.
Shares of Humana have lost 2.4% in a year’s time against the industry’s growth of 30.2%.
Other companies in the same space being serious about capital deployment through share buybacks include Cigna Corp. (CI - Free Report) , Select Medical Holdings Corporation (SEM - Free Report) and Anthem, Inc. .
Cigna has a strong shareholder value-boosting program in place. CI announced a $2-billion accelerated share repurchase in the third quarter. It also declares special dividends from time to time. Management remains optimistic about paying an attractive dividend and generating a cumulative operating cash flow of $50 billion through 2025.
In the third quarter of 2021, Anthem repurchased shares worth $480 million. ANTM expects to buy back shares worth $1.6 billion for 2021 and around 60% of the target has been achieved so far. Anthem has always been aggressively engaged in share buybacks, utilizing its excess capital to add shareholder value.
After halting share buybacks for a short time, Select Medical resumed the same in the third quarter of 2021. SEM bought back shares worth $47.5 million in the period. Also, the board of directors authorized an increase in its share repurchase program on Nov 2, 2021, which will run until the end of 2023. It lifted the buyback program from $500 million to $1 billion.